WHO ICTRP trial
A randomised, double-blind, placebo-controlled study to evaluate if rasagiline…
EUCTR2009-011144-19-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2009-011144-19-IT |
|---|---|
| Public title | A randomised, double-blind, placebo-controlled study to evaluate if rasagiline can improve depressive symptoms and cognitive function in non-demented, idiopathic Parkinson s disease patients. - ACCORDO |
| Scientific title | A randomised, double-blind, placebo-controlled study to evaluate if rasagiline can improve depressive symptoms and cognitive function in non-demented, idiopathic Parkinson s disease patients. - ACCORDO |
| Primary sponsor | LUNDBECK ITALIA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Subjects will be recruited from the Movement Disorders Outpatient Clinics from academic and hospital institutions in Italy. Only subjects with a BDI-IA score > or = 15 at baseline will be enrolled.Subjects have to be under stable treatment… |
| Interventions | Trade Name: AZILECT Pharmaceutical Form: Tablet INN or Proposed INN: Rasagiline Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 1- Pharmaceutical form of the placebo: Tablet Route of administration of the… |
| Registration date | May 11, 2009 |
| Secondary IDs | 12962A |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: